Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mural Oncology

    NASDAQ: MURA · Real-Time Price · USD
    2.44
    -0.01 (-0.41%)
    At close: Jun 17, 2025, 3:59 PM
    2.44
    -0.20%
    After-hours: Jun 17, 2025, 04:04 PM EDT

    Mural Oncology Statistics

    Share Statistics

    Mural Oncology has 17.27M shares outstanding. The number of shares has increased by 1.8% in one year.

    Shares Outstanding

    n/a
    		 17.27M

    Shares Change (YoY)

    n/a
    		 1.8%

    Shares Change (QoQ)

    n/a
    		 0.98%

    Owned by Institutions (%)

    n/a
    		 54.96%

    Shares Floating

    n/a
    		 12.83M

    Failed to Deliver (FTD) Shares

    n/a
    		 866

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 341.87K, so 1.98% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 341.87K

    Short % of Shares Out

    n/a
    		 1.98%

    Short % of Float

    n/a
    		 1.99%

    Short Ratio (days to cover)

    n/a
    		 2.41

    Valuation Ratios

    The PE ratio is -0.42 and the forward PE ratio is -1.11. Mural Oncology's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.42

    Forward PE

    n/a
    		 -1.11

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 0.39

    P/FCF Ratio

    n/a
    		 -0.42

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Mural Oncology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.84, with a Debt / Equity ratio of 0.06.

    Current Ratio

    n/a
    		 5.84

    Quick Ratio

    n/a
    		 5.84

    Debt / Equity

    n/a
    		 0.06

    Debt / EBITDA

    n/a
    		 -0.06

    Debt / FCF

    n/a
    		 -0.06

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,107,879.31

    Employee Count

    n/a
    		 116

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -25.45% in the last 52 weeks. The beta is 3.4, so Mural Oncology's price volatility has been higher than the market average.

    Beta

    n/a
    		 3.4

    52-Week Price Change

    n/a
    		 -25.45%

    50-Day Moving Average

    n/a
    		 2.4

    200-Day Moving Average

    n/a
    		 3.21

    Relative Strength Index (RSI)

    n/a
    		 40.91

    Average Volume (20 Days)

    n/a
    		 4,709,492

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -138.26M

    Net Income

    n/a
    		 -128.51M

    EBITDA

    n/a
    		 -125M

    EBIT

    n/a
    		 -128.51M

    Earnings Per Share (EPS)

    n/a
    		 -7.58
    Full Income Statement

    Balance Sheet

    The company has 115.46M in cash and 8.02M in debt, giving a net cash position of 107.44M.

    Cash & Cash Equivalents

    n/a
    		 115.46M

    Total Debt

    n/a
    		 8.02M

    Net Cash

    n/a
    		 107.44M

    Retained Earnings

    n/a
    		 -159.37M

    Total Assets

    n/a
    		 132.08M

    Working Capital

    n/a
    		 94.5M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -128.54M and capital expenditures -92K, giving a free cash flow of -128.64M.

    Operating Cash Flow

    n/a
    		 -128.54M

    Capital Expenditures

    n/a
    		 -92K

    Free Cash Flow

    n/a
    		 -128.64M

    FCF Per Share

    n/a
    		 -7.59
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    MURA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MURA is $15, which is 509.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 509.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -2.66

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist